04:57 PM EDT, 07/17/2024 (MT Newswires) -- Samuel C. Blackman, Head of R&D, on July 16, 2024, sold 20,000 shares in Day One Biopharmaceuticals ( DAWN ) for $320,226. Following the Form 4 filing with the SEC, Blackman Samuel C. has control over a total of 2,121,081 shares of the company, with 1,121,081 shares held directly and 1,000,000 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1845337/000141588924019681/xslF345X03/form4-07172024_080736.xml

Price: 15.31, Change: -0.34, Percent Change: -2.17